Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
Trend | Peers | Company |
---|---|---|
Is return on equity increasing? | No | No |
Is net profit margin increasing? | Yes | No |
Is asset turnover increasing? | Yes | Yes |
Is equity multiplier increasing? | Yes | No |
Competitors Used |
---|
GSK plc |
Bayer Aktiengesellschaft |
Pfizer Inc. |
Perrigo Company plc |
Moberg Pharma AB (publ) |
Return on Equity Benchmarks | ||||||||
Comparable Companies | ||||||||
GSK1 N | BAYN N | PFE * | PRGO N | MOB | GEKA | |||
Return On Equity | ||||||||
Latest Twelve Months | 23% | -10% | 9% | -4% | -39% | 21% | ||
Fiscal Year - 1 | 41% | -8% | 2% | 0% | NA | 11% | ||
Fiscal Year - 2 | 35% | 12% | 36% | -3% | -3% | 14% | ||
Fiscal Year - 3 | 22% | 3% | 32% | -2% | NA | 14% | ||
Fiscal Year - 4 | 37% | -40% | 10% | 1% | 1% | 17% | ||
Fiscal Year - 5 | 61% | 5% | 17% | 3% | -1% | 10% | ||
Average | 37% | -6% | 18% | -1% | -11% | 14% | ||
Median | 36% | -3% | 14% | -1% | -2% | 14% | ||
Benchmarks | Ticker | |||||||
GSK plc | BMV:GSK1N | |||||||
Bayer Aktiengesellschaft | BMV:BAYNN | |||||||
Pfizer Inc. | BMV:PFE* | |||||||
Perrigo Company plc | BMV:PRGON | |||||||
Moberg Pharma AB (publ) | OM:MOB |
Financial Performance | ||||||||
Comparable Companies | ||||||||
(in millions) | GSK1 N | BAYN N | PFE * | PRGO N | MOB | GEKA | ||
Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
LTM Period | Mar-25 | Mar-25 | Mar-25 | Mar-25 | Mar-25 | Mar-25 | ||
Revenues | ||||||||
Latest Twelve Months | 31,529 | 46,579 | 62,464 | 4,335 | 13 | 18,816 | ||
Fiscal Year | 31,376 | 46,606 | 63,627 | 4,373 | 10 | 18,607 | ||
Fiscal Year - 1 | 30,328 | 47,637 | 59,554 | 4,656 | NA | 16,467 | ||
Fiscal Year - 2 | 29,324 | 50,739 | 101,175 | 4,452 | 0 | 16,820 | ||
Fiscal Year - 3 | 24,696 | 44,081 | 81,288 | 4,139 | NA | 15,487 | ||
Fiscal Year - 4 | 24,354 | 41,400 | 41,651 | 4,088 | 34 | 13,870 | ||
Fiscal Year - 5 | 33,754 | 43,545 | 40,905 | 3,870 | 31 | 12,713 | ||
Net Income | ||||||||
Latest Twelve Months | 3,153 | (3,253) | 7,867 | (165) | (251) | 2,158 | ||
Fiscal Year | 2,575 | (2,552) | 8,020 | (161) | (255) | 2,091 | ||
Fiscal Year - 1 | 4,928 | (2,941) | 2,134 | (4) | (21) | 1,085 | ||
Fiscal Year - 2 | 4,461 | 4,150 | 31,366 | (131) | (16) | 1,366 | ||
Fiscal Year - 3 | 3,316 | 1,000 | 22,413 | (131) | (16) | 1,308 | ||
Fiscal Year - 4 | 4,873 | (15,569) | 6,630 | 44 | 7 | 1,404 | ||
Fiscal Year - 5 | 4,645 | 2,391 | 10,707 | 159 | (8) | 750 | ||
Total Assets | ||||||||
Latest Fiscal Quarter Prior | 58,511 | 119,881 | 221,095 | 10,640 | 632 | 21,312 | ||
Latest Fiscal Quarter | 60,705 | 109,183 | 208,028 | 9,760 | 703 | 24,080 | ||
Fiscal Year | 59,463 | 110,850 | 213,396 | 9,648 | 706 | 23,018 | ||
Fiscal Year - 1 | 59,005 | 116,259 | 226,501 | 10,809 | 635 | 20,697 | ||
Fiscal Year - 2 | 60,146 | 124,877 | 197,205 | 11,017 | 564 | 21,607 | ||
Fiscal Year - 3 | 79,103 | 120,241 | 181,476 | 10,426 | 451 | 21,543 | ||
Fiscal Year - 4 | 80,431 | 116,804 | 154,229 | 11,488 | 481 | 21,341 | ||
Fiscal Year - 5 | 79,692 | 126,174 | 167,594 | 11,301 | 1,210 | 18,530 | ||
Fiscal Year - 6 | 58,066 | 126,732 | 159,422 | 10,983 | 1,252 | 18,077 | ||
Common Equity | ||||||||
Latest Fiscal Quarter Prior | 13,840 | 35,605 | 92,282 | 4,687 | 605 | 9,774 | ||
Latest Fiscal Quarter | 14,157 | 32,447 | 90,338 | 4,364 | 685 | 11,109 | ||
Fiscal Year | 13,671 | 31,908 | 88,203 | 4,319 | 687 | 10,885 | ||
Fiscal Year - 1 | 13,347 | 32,927 | 89,014 | 4,768 | 611 | 9,383 | ||
Fiscal Year - 2 | 10,598 | 38,773 | 95,661 | 4,842 | 534 | 10,153 | ||
Fiscal Year - 3 | 15,055 | 33,020 | 77,201 | 5,152 | 434 | 10,072 | ||
Fiscal Year - 4 | 14,587 | 30,523 | 63,238 | 5,655 | 388 | 8,842 | ||
Fiscal Year - 5 | 11,405 | 47,253 | 63,126 | 5,804 | 1,121 | 7,249 | ||
Fiscal Year - 6 | 3,781 | 45,977 | 63,388 | 5,668 | 594 | 7,428 |